Article Details

U.S. FDA Approves Bristol Myers Squibb and 2seventy bio'sAbecma for Triple-Class ...

Retrieved on: 2024-04-06 13:28:46

Tags for this article:

Click the tags to see associated articles and topics

U.S. FDA Approves Bristol Myers Squibb and 2seventy bio'sAbecma for Triple-Class .... View article details on hiswai:

Excerpt

In early lines of treatment, regimens consisting of combinations of IMiDs, PIs, and anti-CD38 monoclonal antibodies are often used to help manage the ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up